search
Back to results

Caffeine to Reduce Mechanical Ventilation in Preterm Infants

Primary Purpose

Prematurity, Apnea, Respiratory Failure

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Caffeine citrate
Normal saline
Sponsored by
University of Miami
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Prematurity focused on measuring Premature infants, Caffeine, Methylxanthines, Mechanical ventilation, Oxygen, Weaning, Bronchopulmonary dysplasia

Eligibility Criteria

1 Day - 5 Days (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Premature neonates born between 23 and 30 completed weeks of gestation.
  • Requiring mechanical ventilation within the first 5 postnatal days
  • Written-informed parental consent for the study

Exclusion Criteria:

  • Major congenital anomalies
  • Small for gestational age

Sites / Locations

  • NICU, Holtz Children's Hospital, Jackson Health System

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Caffeine Arm

Placebo Arm

Arm Description

Subjects randomized to this arm will receive blinded Caffeine citrate.

Subjects randomized to this arm will receive blinded Placebo (equivalent volume of normal saline).

Outcomes

Primary Outcome Measures

Age at First Successful Extubation
Defined as age of extubation with infant remaining extubated for more than 24 hours.

Secondary Outcome Measures

Survival
Total Duration of Mechanical Ventilation
Total Duration of Oxygen Supplementation
Number of Infants With Bronchopulmonary Dysplasia (BPD)
BPD defined as need for oxygen for at least 28 days and at 36 weeks post-menstrual age.
Survival Without BPD
Discharge alive without BPD. BPD defined as need for oxygen for at least 28 days and at 36 weeks post-menstrual age.

Full Information

First Posted
December 12, 2012
Last Updated
May 17, 2017
Sponsor
University of Miami
search

1. Study Identification

Unique Protocol Identification Number
NCT01751724
Brief Title
Caffeine to Reduce Mechanical Ventilation in Preterm Infants
Official Title
Use of Caffeine to Reduce Length of Mechanical Ventilation in Preterm Infants
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Terminated
Why Stopped
Safety
Study Start Date
December 2012 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
January 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Miami

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Most premature infants require mechanical ventilation for prolonged periods of time and a significant proportion of them develop Bronchopulmonary Dysplasia (BPD). Caffeine is a stimulant of the respiratory center and has been used for the treatment of Apnea of Prematurity in infants not requiring mechanical ventilation or to facilitate weaning from mechanical ventilation by starting therapy shortly before extubation. Recently the use of Caffeine in ventilated infants has been initiated earlier because of the reported reduction in BPD. However there is paucity of data supporting this practice. Because protracted mechanical ventilation and supplemental oxygen increase the risk of developing BPD, a therapy that would facilitate the reduction of the respiratory support and shorten its duration is desirable. Therefore, it is of importance to evaluate the effects of early Caffeine initiation and administration during the course of mechanical ventilation in preterm infants by means of a randomized placebo-controlled trial. Hypothesis: The primary hypothesis of this study is that early use of caffeine in mechanically ventilated preterm infants will reduce the time to first elective extubation and secondarily, that this will reduce the total duration of mechanical ventilation and oxygen supplementation, and reduce the incidence and severity of BPD. Objective: The objective of this trial is to evaluate the effects of early caffeine use during mechanical ventilation on the time to first elective extubation, total duration of mechanical ventilation and oxygen supplementation, and the incidence of BPD. Study Design: This will be a single-center prospective, randomized, double-blind, placebo controlled clinical trial. Population: Premature neonates born between 23 and 30 completed weeks of gestation, who require mechanical ventilation within the first 5 days of life will be enrolled. Infants with major congenital anomalies or small for gestational age will be excluded. Methods: Infants will be randomized within the first 5 days to receive a study drug consisting of either blinded Caffeine citrate or blinded Placebo (equivalent volume of normal saline). Infants will continue to receive the study drug until the first elective extubation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prematurity, Apnea, Respiratory Failure
Keywords
Premature infants, Caffeine, Methylxanthines, Mechanical ventilation, Oxygen, Weaning, Bronchopulmonary dysplasia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
87 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Caffeine Arm
Arm Type
Experimental
Arm Description
Subjects randomized to this arm will receive blinded Caffeine citrate.
Arm Title
Placebo Arm
Arm Type
Placebo Comparator
Arm Description
Subjects randomized to this arm will receive blinded Placebo (equivalent volume of normal saline).
Intervention Type
Drug
Intervention Name(s)
Caffeine citrate
Intervention Description
Enrolled subjects will be randomized to receive a study drug consisting of either blinded Caffeine citrate. Randomization and study drug preparation will be done by the NICU pharmacy. Investigators and clinicians will be blinded to the assigned drug. After randomization, an initial loading dose of 20 mg/Kg of study drug will be followed by a 5 mg/Kg/day maintenance dose. The assigned study drug will be administered intravenous or orally as determined by the clinical team. Infants will continue to receive the study drug until 12 hours prior to the first elective extubation.
Intervention Type
Other
Intervention Name(s)
Normal saline
Intervention Description
Enrolled subjects will be randomized to receive a study drug consisting of blinded Placebo (equivalent volume of normal saline). Randomization and study drug preparation will be done by the NICU pharmacy. Investigators and clinicians will be blinded to the assigned drug. After randomization, an initial loading dose of 20 mg/Kg of study drug will be followed by a 5 mg/Kg/day maintenance dose. The assigned study drug will be administered intravenous or orally as determined by the clinical team. Infants will continue to receive the study drug until 12 hours prior to the first elective extubation.
Primary Outcome Measure Information:
Title
Age at First Successful Extubation
Description
Defined as age of extubation with infant remaining extubated for more than 24 hours.
Time Frame
From birth to until 36 weeks postmenstrual age
Secondary Outcome Measure Information:
Title
Survival
Time Frame
From the time of randomization up to 36 weeks corrected age, or until the time of discharge or death
Title
Total Duration of Mechanical Ventilation
Time Frame
From the time of first intubation until the last extubation, up to 36 weeks corrected age
Title
Total Duration of Oxygen Supplementation
Time Frame
From the time of first initiation until the last day of oxygen supplementation, up to 36 weeks corrected age
Title
Number of Infants With Bronchopulmonary Dysplasia (BPD)
Description
BPD defined as need for oxygen for at least 28 days and at 36 weeks post-menstrual age.
Time Frame
Evaluated at 36 weeks corrected postmenstrual age
Title
Survival Without BPD
Description
Discharge alive without BPD. BPD defined as need for oxygen for at least 28 days and at 36 weeks post-menstrual age.
Time Frame
From the time of randomization until 36 weeks corrected age, discharge or death
Other Pre-specified Outcome Measures:
Title
Number of Infants With Pulmonary Hemorrhage
Time Frame
From enrollment until 36 weeks postmenstrual age, discharge or death
Title
Number of Infants With Necrotizing Enterocolitis
Time Frame
From enrollment until 36 weeks postmenstrual age, discharge or death
Title
Number of Infants With Septicemia
Description
Septicemia defined as positive blood culture
Time Frame
From enrollment until 36 weeks postmenstrual age, discharge or death
Title
Number of Infants With Severe Intraventricular Hemorrhage
Description
Severe intraventricular hemorrhage defined as grade III or higher
Time Frame
From enrollment until 36 weeks postmenstrual age, discharge or death
Title
Number of Infants With Severe Retinopathy of Prematurity
Description
Severe retinopathy of prematurity defined as stage 3 or higher
Time Frame
From enrollment until 36 weeks postmenstrual age, discharge or death

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
5 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Premature neonates born between 23 and 30 completed weeks of gestation. Requiring mechanical ventilation within the first 5 postnatal days Written-informed parental consent for the study Exclusion Criteria: Major congenital anomalies Small for gestational age
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eduardo Bancalari, M.D.
Organizational Affiliation
University of Miami
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Nelson Claure, M.Sc., Ph.D.
Organizational Affiliation
University of Miami
Official's Role
Principal Investigator
Facility Information:
Facility Name
NICU, Holtz Children's Hospital, Jackson Health System
City
Miami
State/Province
Florida
ZIP/Postal Code
33136
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
29519541
Citation
Amaro CM, Bello JA, Jain D, Ramnath A, D'Ugard C, Vanbuskirk S, Bancalari E, Claure N. Early Caffeine and Weaning from Mechanical Ventilation in Preterm Infants: A Randomized, Placebo-Controlled Trial. J Pediatr. 2018 May;196:52-57. doi: 10.1016/j.jpeds.2018.01.010. Epub 2018 Mar 6.
Results Reference
derived

Learn more about this trial

Caffeine to Reduce Mechanical Ventilation in Preterm Infants

We'll reach out to this number within 24 hrs